![](/img/cover-not-exists.png)
Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for Small-Cell Lung Cancer: Primary and Correlative Biomarker Analyses
Owonikoko, Taofeek K., Niu, Huifeng, Nackaerts, Kristiaan, Csoszi, Tibor, Ostoros, Gyula, Mark, Zsuzsanna, Baik, Christina, Joy, Anil Abraham, Chouaid, Christos, Jaime, Jesus Corral, Kolek, Vitezslav,Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.10.013
Date:
October, 2019
File:
PDF, 1.72 MB
english, 2019